Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Morphine hydrochloride [USP:JAN]
RN: 52-26-6
UNII: J28GE0ROVX
InChIKey: XCKKIKBIPZJUET-VYKNHSEDSA-N

Note

  • The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Molecular Formula

  • C17-H19-N-O3.Cl-H

Molecular Weight

  • 321.802
 

Classification Codes

  • Drug / Therapeutic Agent
  • Human Data
  • Mutation Data
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Morphine hydrochloride [USP:JAN]

Synonyms

  • Ampek
  • EINECS 200-136-2
  • Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-, hydrochloride
  • Morphine chlorhydrate
  • Morphine chloride
  • Morphine HCl
  • Morphine hydrochloride
  • Theba-Intran
  • Thebametten
  • UNII-J28GE0ROVX

Systematic Names

  • Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, hydrochloride, (5-alpha,6-alpha)-
  • Morphine hydrochloride

Registry Numbers

CAS Registry Number

  • 52-26-6

FDA UNII

  • J28GE0ROVX

System Generated Number

  • 0000052266

Molecular Formulas

Molecular Formula

  • C17-H19-N-O3.Cl-H

Molecular Formula Fragments

  • C17-H19-N-O3
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

InChI=1S/C17H19NO3.ClH/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;/h2-5,10-11,13,16,19-20H,6-8H2,1H3;1H/t10-,11+,13-,16-,17-;/m0./s1

InChIKey

XCKKIKBIPZJUET-VYKNHSEDSA-N

Smiles

Cl.CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 175mg/kg (175mg/kg)   Chemical and Pharmaceutical Bulletin. Vol. 7, Pg. 372, 1959.
guinea pig LD50 subcutaneous 340mg/kg (340mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 137, Pg. 375, 1962.
guinea pig LDLo intraarterial 60mg/kg (60mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928.
guinea pig LDLo intravenous 60mg/kg (60mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928.
mouse LD50 intracrebral 3500ug/kg (3.5mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 63(3), Pg. 93S, 1967.
mouse LD50 intraperitoneal 148mg/kg (148mg/kg)   British Journal of Pharmacology. Vol. 73, Pg. 887, 1981.
mouse LD50 intravenous 180mg/kg (180mg/kg)   Archives of Toxicology, Supplement. Vol. 7, Pg. 90, 1984.
mouse LD50 oral 745mg/kg (745mg/kg)   Japanese Journal of Pharmacology. Vol. 18, Pg. 406, 1968.
mouse LD50 parenteral 440mg/kg (440mg/kg)   Wakayama Medical Report. Vol. 26(4), Pg. 65, 1983.
mouse LD50 subcutaneous 354mg/kg (354mg/kg)   Kiso to Rinsho. Clinical Report. Vol. 5, Pg. 1787, 1971.
rabbit LD50 intraperitoneal 500mg/kg (500mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)		 Journal of Pharmacology and Experimental Therapeutics. Vol. 60, Pg. 14, 1937.
rabbit LD50 intravenous 135mg/kg (135mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Archives Internationales de Pharmacodynamie et de Therapie. Vol. 85, Pg. 387, 1951.
rabbit LD50 subcutaneous 398mg/kg (398mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 66, Pg. 182, 1939.
rabbit LDLo oral 700mg/kg (700mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: FOOD INTAKE (ANIMAL)

BEHAVIORAL: MUSCLE WEAKNESS		 Archives Internationales de Pharmacodynamie et de Therapie. Vol. 14, Pg. 289, 1905.
rat LD50 intravenous 265mg/kg (265mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 115, Pg. 213, 1958.
rat LD50 oral 335mg/kg (335mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 221, Pg. 105, 1976.
rat LD50 subcutaneous 480mg/kg (480mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 115, Pg. 213, 1958.
rat LD50 unreported 310mg/kg (310mg/kg) BEHAVIORAL: ANALGESIA Pharmacological Research Communications. Vol. 5, Pg. 175, 1973.
rat LDLo intraspinal 2mg/kg (2mg/kg) BEHAVIORAL: ANALGESIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: IRRITABILITY		 Acta Pharmacologica et Toxicologica. Vol. 56, Pg. 50, 1985.
women TDLo intraspinal 40ug/kg (0.04mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE		 Israel Journal of Medical Sciences. Vol. 21, Pg. 855, 1985.
women TDLo parenteral 720ug/kg/3D-I (0.72mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Anesthesia and Analgesia Vol. 63, Pg. 1142, 1984.